Related references
Note: Only part of the references are listed.EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
George C. Drosos et al.
ANNALS OF THE RHEUMATIC DISEASES (2022)
Assessing the validity of QRISK3 in predicting cardiovascular events in systemic lupus erythematosus
Lisa Zhu et al.
LUPUS SCIENCE & MEDICINE (2022)
Anti-phospholipid antibodies do not predict damage in SLE patients in the 21st century-an observational study from the Lupus-Cruces cohort
Amaia Ugarte et al.
RHEUMATOLOGY (2022)
QRISK3 relation to carotid plaque is higer than that of score in patients with systemic lupus erythematosus
Juan Carlos Quevedo-Abeledo et al.
RHEUMATOLOGY (2022)
Extent of vascular plaque predicts future cardiovascular events in patients with systemic lupus erythematosus
Jyoti Bakshi et al.
RHEUMATOLOGY (2022)
Cardiovascular disease risk and pathogenesis in systemic lupus erythematosus
Christopher B. Oliveira et al.
SEMINARS IN IMMUNOPATHOLOGY (2022)
Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus
George C. Drosos et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2021)
The Relationship between Cardiovascular Risk Scores and Several Markers of Subclinical Atherosclerosis in an Asymptomatic Population
Ovidiu Mitu et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies
Manuel Francisco Ugarte-Gil et al.
LUPUS SCIENCE & MEDICINE (2021)
Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus
Jagan Sivakumaran et al.
LUPUS SCIENCE & MEDICINE (2021)
Predictive Utility of Cardiovascular Risk Prediction Algorithms in Inflammatory Rheumatic Diseases: A Systematic Review
Keith Colaco et al.
JOURNAL OF RHEUMATOLOGY (2020)
Comparative Risks of Cardiovascular Disease in Patients With Systemic Lupus Erythematosus, Diabetes Mellitus, and in General Medicaid Recipients
Medha Barbhaiya et al.
ARTHRITIS CARE & RESEARCH (2020)
Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors
Laurent Arnaud et al.
RHEUMATOLOGY (2020)
Systemic lupus erythematosus; stroke and myocardial infarction risk: a systematic review and meta-analysis
Jinoos Yazdany et al.
RMD OPEN (2020)
Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study
Matteo Nicola Dario Di Minno et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2019)
Progression of atherosclerosis versus arterial stiffness with age within and between arteries in systemic lupus erythematosus
Paola C. Roldan et al.
RHEUMATOLOGY INTERNATIONAL (2019)
EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Development of a systemic lupus erythematosus cardiovascular risk equation
Michelle A. Petri et al.
LUPUS SCIENCE & MEDICINE (2019)
Progression of subclinical atherosclerosis in systemic lupus erythematosus versus rheumatoid arthritis: the impact of low disease activity
Evrydiki Kravvariti et al.
RHEUMATOLOGY (2018)
Subclinical parameters of arterial stiffness and arteriosclerosis correlate with QRISK3 in systemic lupus erythematosus
Monica Vazquez-Del Mercado et al.
PLOS ONE (2018)
QRISK3 improves detection of cardiovascular disease risk in patients with systemic lupus erythematosus
Nicola Edwards et al.
LUPUS SCIENCE & MEDICINE (2018)
Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis
Kashif Jafri et al.
CLINICAL RHEUMATOLOGY (2018)
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study
Julia Hippisley-Cox et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Assessment of subclinical atherosclerosis in systemic lupus erythematosus: A systematic review and meta-analysis
Pauline Henrot et al.
JOINT BONE SPINE (2017)
Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls
Johanna T. Gustafsson et al.
PLOS ONE (2017)
Survival in adults and children with systemic lupus erythematosus: a systematic review and Bayesian meta-analysis of studies from 1950 to 2016
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2017)
Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis
Maria G. Tektonidou et al.
AUTOIMMUNITY REVIEWS (2017)
Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis
Guo-Cui Wu et al.
AUTOIMMUNITY REVIEWS (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Modified Framingham Risk Factor Score for Systemic Lupus Erythematosus
Murray B. Urowitz et al.
JOURNAL OF RHEUMATOLOGY (2016)
Brief Report: Trends in Hospitalizations Due to Acute Coronary Syndromes and Stroke in Patients With Systemic Lupus Erythematosus, 1996 to 2012
Maria G. Tektonidou et al.
ARTHRITIS & RHEUMATOLOGY (2016)
A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys
Kaveh Hajifathalian et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
Predictors of cardiovascular events in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis
Flavia Ballocca et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2015)
2013 ACC/AHA Guideline on the Assessment of Cardiovascular Risk A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
David C. Goff et al.
CIRCULATION (2014)
Progression of carotid atherosclerosis in patients with systemic lupus erythematosus
Rosa W. Telles et al.
CLINICAL RHEUMATOLOGY (2013)
Antiphospholipid antibodies and sub-clinical atherosclerosis in the Coronary Artery Risk Development in Young Adults (CARDIA) cohort
Darcy S. Majka et al.
INFLAMMATION RESEARCH (2013)
Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2012)
Mortality Profile Related to Systemic Lupus Erythematosus: A Multiple Cause-of-death Analysis
Deborah C. C. Souza et al.
JOURNAL OF RHEUMATOLOGY (2012)
Integrating Information From Novel Risk Factors With Calculated Risks The Critical Impact of Risk Factor Prevalence
Albertus J. Kooter et al.
CIRCULATION (2011)
The Association of Framingham and Reynolds Risk Scores With Incidence and Progression of Coronary Artery Calcification in MESA (Multi-Ethnic Study of Atherosclerosis)
Andrew P. DeFilippis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Predictors of progression in atherosclerosis over 2 years in systemic lupus erythematosus
Adnan N. Kiani et al.
RHEUMATOLOGY (2011)
Cardiovascular risk scores in the prediction of subclinical atherosclerosis in young adults: evidence from the cardiovascular risk in a young Finns study
Juho R. H. Raiko et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2010)
Risk Factors for Thrombosis and Primary Thrombosis Prevention in Patients With Systemic Lupus Erythematosus With or Without Antiphospholipid Antibodies
Maria G. Tektonidou et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus
Mary J. Roman et al.
ARTHRITIS AND RHEUMATISM (2007)
Prevalence of conventional and lupus-specific risk factors for cardiovascular disease in patients with systemic lupus erythematosus: A case-control study
Rupa Bessant et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: A report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology
Mary J. Roman et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus
C. P. Chung et al.
LUPUS (2006)
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus
MJ Roman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Estimation of ten-year risk of fatal cardiovascular disease in Europe:: the SCORE project
RM Conroy et al.
EUROPEAN HEART JOURNAL (2003)
Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the Prospective Cardiovascular Munster (PROCAM) study
G Assmann et al.
CIRCULATION (2002)
Share Paper
